ZIOPHARM ONCOLOGY INC·5

Jan 3, 5:13 PM ET

Youssoufian Hagop 5

5 · ZIOPHARM ONCOLOGY INC · Filed Jan 3, 2013

Insider Transaction Report

Form 5
Period: 2012-12-31
Youssoufian Hagop
Executive VP, CMO
Transactions
  • Tax Payment

    Common Stock

    2012-07-11$6.06/sh15,740$95,38499,640 total
Footnotes (1)
  • [F1]Disposition represents shares withheld to satisfy withholding tax obligations upon the vesting of a restricted stock grant.

Documents

1 file
  • 5
    doc5.xmlPrimary

    FORM 5 SUBMISSION